Eichelbaum M, Ekbom K, Bertilsson L, Ringberger V A, Rane A
Eur J Clin Pharmacol. 1975 Jun 13;8(5):337-41. doi: 10.1007/BF00562659.
Carbamazepine (Tegretol) was administered orally to four patients as a single dose, and one week later three times daily for 15-21 days. The plasma half-lives of the drug were shorter in all patients after multiple doses (20.9 +/- 5.0 hours) than after the initial single dose (35.6 +/- 15.3 hours). During the multiple dose the plasma concentrations of the metabolite carbamazepine-10,11-epoxide followed those of the parent drug. The steady-state plasma concentrations expected during multiple doses were calculated from the pharmacokinetic parameters obtained in the single dose studies. The calculated levels were higher (17.2+/-7.2 mug/ml) than the observed maximal concentrations (8.4+/-1.6 mug/ml on day 4), which were obtained 3-4 days after starting the multiple doses. The levels tended to decrease further during the experimental period. The results suggest that carbamazepine induces its own metabolism in man.
对4名患者口服卡马西平( Tegretol ),单次给药,一周后每日3次,共给药15 - 21天。多次给药后,所有患者药物的血浆半衰期(20.9±5.0小时)均短于初次单次给药后(35.6±15.3小时)。多次给药期间,代谢产物卡马西平-10,11-环氧化物的血浆浓度与母体药物的血浆浓度呈平行变化。根据单次给药研究获得的药代动力学参数计算多次给药期间预期的稳态血浆浓度。计算所得浓度(17.2±7.2μg/ml)高于观察到的最大浓度(多次给药开始后3 - 4天测得的第4天为8.4±1.6μg/ml)。在实验期间,浓度有进一步下降的趋势。结果提示卡马西平在人体内可诱导自身代谢。